Testing effectiveness (Phase 2)Study completedNCT02521649
What this trial is testing
Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer
Who this might be right for
Gastric Cancer
Cancer Advances Inc. 52
Showing 20 of 0 results